Skip to main content
Satoshi Holdings Co., Ltd. logo

Satoshi Holdings Co., Ltd. — Investor Relations & Filings

Ticker · 223310 ISIN · KR7223310004 KO Financial and insurance activities
Open in API
Filings indexed 473 across all filing types
Latest filing 2021-12-07 AGM Information
Country KR South Korea
Listing KO 223310

About Satoshi Holdings Co., Ltd.

http://www.skpolytech.com/

Satoshi Holdings Co., Ltd., formerly DeepMind Platform Co Ltd, is a company with diverse business operations. Its activities have included an online commerce segment focused on health functional foods, pharmaceutical products, and other consumer goods, as well as a smart car division involved in the manufacture and sale of IT products like dash cams. The company has also stated a strategic direction to become a digital asset securities firm, with the goal of building a regulated, full-stack crypto finance ecosystem.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice regarding the rescheduling of an Extraordinary General Meeting (EGM) for 'Kyungnam Pharm Healthcare'. It details the change in date, location, and agenda items (such as articles of incorporation changes and director appointments). This falls under the category of materials related to shareholder meetings and proxy solicitation, specifically the notice of meeting and agenda, which is classified as Proxy Solicitation & Information Statement (PSI).
2021-12-07 Korean
주요사항보고서(영업정지)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding a business suspension (영업정지) due to regulatory violations. This type of disclosure is a mandatory regulatory filing for material corporate events in the Korean market. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-12-03 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (금융감독원) in South Korea. It details the completion of a tangible asset transfer (disposal of mask production equipment) between Kyungnam Pharm Healthcare and Blueberry NFT. Since this is a regulatory filing regarding a specific corporate transaction (asset disposal) that does not fit into the other specific categories like M&A (which usually refers to corporate mergers/takeovers) or share issues, it is best classified as a general Regulatory Filing (RNS).
2021-11-30 Korean
[기재정정]최대주주변경을수반하는주식양수도계약체결
M&A Activity Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a 'Share Transfer Agreement involving a change in the largest shareholder'. It details the amendment of payment dates for a stock purchase agreement. Since this is a formal regulatory announcement regarding corporate control and share transfer agreements, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'M&A Activity' (which typically refers to corporate mergers/takeovers).
2021-11-26 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice regarding the rescheduling of an Extraordinary General Meeting (EGM) for Kyungnam Pharm Healthcare. It details the change in date and provides information about the meeting agenda, such as the election of directors and amendments to the articles of incorporation. This type of document, which provides information to shareholders regarding an upcoming meeting and requests their participation/vote, is classified as a Proxy Solicitation & Information Statement (PSI).
2021-11-19 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the 11th fiscal period of Kyungnam Pharm Healthcare Co., Ltd., covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.